Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
Clinical trial NCT02042391 · COMPLETED
Trial details
- NCT number
- NCT02042391
- Sponsor
- Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-03
- Primary completion
- 2021-07-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.